Characterization of Trp(+) reversions in Escherichia coli strain WP2uvrA.
The Escherichia coli strain WP2uvrA is widely used in general mutagenicity screening tests because of its high sensitivity to many kinds of mutagens and it serves as a supplement to the standard Salmonella typhimurium tester strains. In contrast to Salmonella His(+) revertants, E.coli Trp(+) revertants have not been characterized at the molecular level. In this study we found that in the trpE65 allele of WP2uvrA the triplet that codes for the fourth amino acid from the N-terminus of anthranilate synthetase was an ochre stop codon (TAA) instead of a glutamine codon (CAA). In spontaneous Trp(+) revertants the ochre codon had been changed to glutamine (CAA), lysine (AAA), glutamic acid (GAA), leucine (TTA), serine (TCA) or tyrosine (TAC, TAT). Since tryptophan prototrophy could also be restored by ochre suppressor mutations at the anticodon sites in the genes for tRNA(Glu) (glnU), tRNA(Lys) (lysT) and tRNA(Tyr) (tyrT, tyrU), the Trp(+) reversion system with E.coli WP2uvrA detected five types of base substitutions, A.T-->T.A, A.T-->C.G, A.T-->G.C, G.C-->A.T and G.C-->T.A. About 30-50% of Trp(+) revertants induced by N-ethyl-N'-nitro-N-nitrosoguanidine, captan and angelicin plus UVA irradiation were attributable to reversion at the trpE65 ochre locus; the others were attributable to suppressor mutations. In contrast, almost all revertants induced by N-methyl-N'-nitro-N-nitrosoguanidine, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone and furylfuramide were caused by suppressor mutations. Thus, the high mutagen sensitivity of WP2uvrA is due to several target sites consisting of A.T base pairs (trpE65, lysT) and G.C base pairs (glnU, tyrT, tyrU).
Ohta
Toshihiro
T
School of Life Science, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan. ohta@ls.toyaku.ac.jp
Tokishita
Shin-ichi
S
Tsunoi
Rumi
R
Ohmae
Satoru
S
Yamagata
Hideo
H
D000251:Adenosine Triphosphatases / Q000235:genetics; D000595:Amino Acid Sequence; D000878:Anthranilate Synthase / Q000235:genetics; D020029:Base Pairing; D001483:Base Sequence; D002215:Captan / Q000494:pharmacology; D018388:Codon, Terminator; D004268:DNA-Binding Proteins / Q000235:genetics; D004926:Escherichia coli / Q000187:drug effects / Q000235:genetics*; D029968:Escherichia coli Proteins / Q000187:drug effects / Q000235:genetics; D005663:Furans / Q000494:pharmacology; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology; D008969:Molecular Sequence Data; D009153:Mutagens / Q000633:toxicity; D009154:Mutation; D012352:RNA, Transfer, Glu / Q000235:genetics; D012357:RNA, Transfer, Lys / Q000235:genetics; D012365:RNA, Transfer, Tyr / Q000235:genetics; D013489:Suppression, Genetic; D014364:Tryptophan
D018388:Codon, Terminator; D004268:DNA-Binding Proteins; D029968:Escherichia coli Proteins; D005663:Furans; D009153:Mutagens; D012352:RNA, Transfer, Glu; D012357:RNA, Transfer, Lys; D012365:RNA, Transfer, Tyr; D008769:Methylnitronitrosoguanidine; C054121:3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone; D014364:Tryptophan; C068631:UvrA protein, E coli; D000251:Adenosine Triphosphatases; D000878:Anthranilate Synthase; D002215:Captan